Navigation Links
Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
Date:9/24/2008

didate is intravenous iclaprim, a potent antibacterial that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). The clinical programme for the first indication, complicated skin and skin structure infections (cSSSI), has been completed. The submission of the NDA to the US FDA was completed in March 2008. The FDA has defined that the Prescription Drug User Fee Act (PDUFA) goal date will be 16 January 2009. Arpida submitted a Marketing Authorisation Application for intravenous iclaprim with EMEA in July 2008. EMEA notified that it had accepted the MAA for review in August 2008.

In December 2007, Arpida announced the enrolment of the first patients in a Phase II clinical study with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare associated pneumonia (HCAP).

In May 2008, Arpida announced the enrolment of the first patients in a Phase II 'intravenous-to-oral' switch trial. Iclaprim could be offered not only as an intravenous therapy for hospital use in acute situations, but also as an oral formulation, allowing early patient discharge followed by outpatient treatment. This switch could be a valuable instrument in reducing healthcare costs and enhancing patient comfort.

Arpida's fourth most advanced antibiotic programme, AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 exhibited potent activity against a large panel of pneumococcal clinical isolates including those resistant to currently used drugs. Promising results of "first-in-man" studies with AR-709 were published in March 2007.

An additional compound, AR-2474, has achieved in vivo proof of concept. AR-2474 has been shown to be effective in eradicating pathogens in preclinical models of skin infection and nasal carriage.

Apart from the antibiotic programmes
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Arpida Provides Further Comments on the Pivotal Phase III Trials
3. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...   Medical Equipment Solutions, Corp. are pleased ... of Defense (US Army) contract valued at over $2 ... diagnostic machine and technical support staffing. As an 8-A ... Business Administration (SBA), Medical Equipment is proud to support ... medical diagnostic equipment. The SBA 8-A certification is a ...
(Date:7/30/2014)... INCLINE VILLAGE, Nev. , July 30, 2014 /PRNewswire/ ... today announced that company management will participate in the ... Boston , Massachusetts. The conference will occur on ... About PDL BioPharma, Inc. PDL BioPharma ... primarily of its Queen et al. antibody humanization patents ...
(Date:7/29/2014)... CAMBRIDGE, Mass. and HERZLIYA PITUACH, ... Inc. (OTCQX and NASDAQ OMX First North Premier, ... announces today that it has initiated the screening of ... trial exploring the safety and efficacy of bertilimumab in ... open-label trial will enroll 10-15 patients who will receive ...
Breaking Medicine Technology:Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 3Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 4Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 5
... A Duke University pioneer in personalized medicine at today,s ... Conference said physicians must lead the way in changing ... care. , Dr. Ralph Snyderman, director of the Duke ... personalized medicine based on genetic and other individual patient ...
... 1 This fall, dog owners in New York City ... walk in the park. Veterinarians on the Mobile Dog Heart ... with a soundproof medical unit to perform free heart examinations ... disease. , (Photo: http://www.newscom.com/cgi-bin/prnh/20091001/CG85941 ) , In addition to ...
Cached Medicine Technology:Personalized Medicine Expert: Don't 'Fix It,' 'Predict It' 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 3
(Date:7/31/2014)... The study, The Truth Behind Variation in ... care payments for four clinical areas—congestive heart failure, acute ... and knees). Using the definition of episodes of ... program, the study examines these clinical areas within the ... , “Our study reaffirms that, in most instances, the ...
(Date:7/30/2014)... Calling all runners in the Richmond, VA region. ... host a monthly Runner’s Injury Clinic at the ... the second Monday of each month through the end of ... 10 and December 8. , The clinics run from ... running shoes and attire, will receive a complimentary evaluation of ...
(Date:7/30/2014)... Park Cities Pet Sitter President , ... month to reinforce best practices when communicating with fellow ... institute the meetings when she realized how much more ... over the past decade. Even with the addition ... quicker processing of customer requests and information, and ...
(Date:7/30/2014)... (SCID) can be successfully treated with a transplant of ... Sloan Kettering,s Richard J. O,Reilly, MD, a world-renowned pioneer ... be published in the July 30 issue of the ... is a group of inherited disorders that cause the ... babies no longer have the ability to fight off ...
(Date:7/30/2014)... Washington, DC and Malaysia (PRWEB) July 30, 2014 ... impact lives through education by LTT Global an award ... been pioneering learning on the go since 2004. , ... free and quality learning content. MMU has links ... providers, universities, organizations, NGOs’ and subject matter experts from ...
Breaking Medicine News(10 mins):Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 2Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 4Health News:Transplantation shown to be highly effective in treating immune deficiency in children 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 3
... of getting the heart disease in higher among teenagers ... de Simone and other researchers from the New York ... communities in Arizona, Oklahoma, and North and South Dakota, ... data from examinations of 460 participants aged 14-20 years ...
... In case you thought that you were a great exercise ... of urban air pollution, you might have to do a ... an environmentalist exhaust and smoke from buses, cars etc can ... this danger is expressed by Dr. Joseph T. Cooke, Associate ...
... by researchers from Cornell University has pointed out to the ... consequence of acid rain// and alteration in the soil nature ... establishment of factories in the U.S. ,The sugar ... eastern United States because of its high-priced lumber, syrup and ...
... the area of personalized genetics will soon enable people ... //This will be possible by scanning and deciphering the ... ,This is indeed a major achievement that can ... permitting the medical specialists to advice them based on ...
... after eating (traditionally called European siesta) has been confirmed by ... levels//. ,Brain cells responsible for mind and body ... switched off after eating, and thus we are in need ... ,A tiny protein called orexins was released from ...
... sponsored conference on aviation flu has called for ... involving all relevant institutions across the globe, including ... watchers and wildlife conservation societies to check spread ... attending the conference convened by the UN Food ...
Cached Medicine News:Health News:Growth Of Maple Trees Affected By Acid Rain 2Health News:Growth Of Maple Trees Affected By Acid Rain 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: